329.7500 5.20 (1.60%)
NSE Jun 27, 2025 15:31 PM
Volume: 236.2K
 

329.75
1.60%
Emkay
Advanced Enzymes' (ADVENZY) Q4FY18 results were in line with our estimate. Revenue stood at Rs1.08bn, up 26% yoy (Emkay Est: Rs1.08bn). US, India, Asia, Europe and Others geographies grew by 36%, 7%, 281%, 27% and 154% yoy, respectively. Revenue growth was driven by Human Nutrition (+36% yoy | 76% of revenue), Industrial Processing (+27% yoy | 5% of Rev.) and Animal Healthcare (5% yoy | 14% of Rev);...
Advanced Enzyme Technologies Ltd. is trading above its 150 day SMA of 318.3
More from Advanced Enzyme Technologies Ltd.
Recommended